Your browser doesn't support javascript.
loading
Suitability and Allocation of Protein-Containing Foods According to Protein Tolerance in PKU: A 2022 UK National Consensus.
Gama, Maria Inês; Adam, Sarah; Adams, Sandra; Allen, Heather; Ashmore, Catherine; Bailey, Sarah; Cochrane, Barbara; Dale, Clare; Daly, Anne; De Sousa, Giana; Donald, Sarah; Dunlop, Carolyn; Ellerton, Charlotte; Evans, Sharon; Firman, Sarah; Ford, Suzanne; Freedman, Francine; French, Moira; Gaff, Lisa; Gribben, Joanna; Grimsley, Anne; Herlihy, Ide; Hill, Melanie; Khan, Farzana; McStravick, Nicola; Millington, Chloe; Moran, Nicola; Newby, Camille; Nguyen, Patty; Purves, Janet; Pinto, Alex; Rocha, Júlio César; Skeath, Rachel; Skelton, Amy; Tapley, Simon; Woodall, Alison; Young, Carla; MacDonald, Anita.
Afiliación
  • Gama MI; Birmingham Women's and Children's NHS Foundation Trust, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
  • Adam S; Nutrition and Metabolism, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
  • Adams S; Royal Hospital for Children, Glasgow G51 4TF, UK.
  • Allen H; Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK.
  • Ashmore C; Sheffield Children's NHS Foundation Trust, Sheffield S10 2TH, UK.
  • Bailey S; Birmingham Women's and Children's NHS Foundation Trust, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
  • Cochrane B; Cardiff and Vale UHB, Cardiff CF14 4XW, UK.
  • Dale C; Royal Hospital for Children, Glasgow G51 4TF, UK.
  • Daly A; University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK.
  • De Sousa G; Birmingham Women's and Children's NHS Foundation Trust, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
  • Donald S; Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
  • Dunlop C; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Ellerton C; Royal Hospital for Children and Young People, Edinburgh EH16 4SA, UK.
  • Evans S; University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK.
  • Firman S; Birmingham Women's and Children's NHS Foundation Trust, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
  • Ford S; Guy's and St Thomas' NHS Foundation Trust, London SE1 7EU, UK.
  • Freedman F; North Bristol NHS Trust, Bristol BS10 5NB, UK.
  • French M; University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK.
  • Gaff L; University Hospitals of Leicester NHS Trust, Leicester LE1 5WW, UK.
  • Gribben J; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Grimsley A; Evelina London Children's Healthcare, London SE1 7EH, UK.
  • Herlihy I; Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
  • Hill M; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Khan F; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK.
  • McStravick N; Bradford Teaching Hospitals NHS Foundation Trust, Bradford BD5 0NA, UK.
  • Millington C; Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
  • Moran N; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Newby C; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK.
  • Nguyen P; Bristol Royal Hospital for Children, Bristol BS2 8BJ, UK.
  • Purves J; University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK.
  • Pinto A; Royal Hospital for Children and Young People, Edinburgh EH16 4SA, UK.
  • Rocha JC; Birmingham Women's and Children's NHS Foundation Trust, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
  • Skeath R; Nutrition and Metabolism, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
  • Skelton A; CINTESIS, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
  • Tapley S; Reference Centre of Inherited Metabolic Diseases, Centro Hospitalar Universitario de Lisboa Central, 1169-045 Lisboa, Portugal.
  • Woodall A; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
  • Young C; Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
  • MacDonald A; University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8HW, UK.
Nutrients ; 14(23)2022 Nov 24.
Article en En | MEDLINE | ID: mdl-36501017
Introduction: There is little practical guidance about suitable food choices for higher natural protein tolerances in patients with phenylketonuria (PKU). This is particularly important to consider with the introduction of adjunct pharmaceutical treatments that may improve protein tolerance. Aim: To develop a set of guidelines for the introduction of higher protein foods into the diets of patients with PKU who tolerate >10 g/day of protein. Methods: In January 2022, a 26-item food group questionnaire, listing a range of foods containing protein from 5 to >20 g/100 g, was sent to all British Inherited Metabolic Disease Group (BIMDG) dietitians (n = 80; 26 Inherited Metabolic Disease [IMD] centres). They were asked to consider within their IMD dietetic team when they would recommend introducing each of the 26 protein-containing food groups into a patient's diet who tolerated >10 g to 60 g/day of protein. The patient protein tolerance for each food group that received the majority vote from IMD dietetic teams was chosen as its tolerance threshold for introduction. A virtual meeting was held using Delphi methodology in March 2022 to discuss and agree final consensus. Results: Responses were received from dietitians from 22/26 IMD centres (85%) (11 paediatric, 11 adult). For patients tolerating protein ≥15 g/day, the following foods were agreed for inclusion: gluten-free pastas, gluten-free flours, regular bread, cheese spreads, soft cheese, and lentils in brine; for protein tolerance ≥20 g/day: nuts, hard cheeses, regular flours, meat/fish, and plant-based alternative products (containing 5−10 g/100 g protein), regular pasta, seeds, eggs, dried legumes, and yeast extract spreads were added; for protein tolerance ≥30 g/day: meat/fish and plant-based alternative products (containing >10−20 g/100 g protein) were added; and for protein tolerance ≥40 g/day: meat/fish and plant-based alternatives (containing >20 g/100 g protein) were added. Conclusion: This UK consensus by IMD dietitians from 22 UK centres describes for the first time the suitability and allocation of higher protein foods according to individual patient protein tolerance. It provides valuable guidance for health professionals to enable them to standardize practice and give rational advice to patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenilcetonurias Tipo de estudio: Guideline / Qualitative_research Límite: Animals País/Región como asunto: Europa Idioma: En Revista: Nutrients Año: 2022 Tipo del documento: Article Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenilcetonurias Tipo de estudio: Guideline / Qualitative_research Límite: Animals País/Región como asunto: Europa Idioma: En Revista: Nutrients Año: 2022 Tipo del documento: Article Pais de publicación: Suiza